Tag: adverse event reporting
Post-market studies on generic drug safety: clinical follow-up
By Joe Barnett On 17 Jun, 2026 Comments (0)
Explore how post-market studies ensure generic drug safety through clinical follow-up, FDA surveillance, and adverse event reporting.
View MoreAdverse Event Monitoring for Biosimilars: How Safety Surveillance Keeps Patients Protected
By Joe Barnett On 3 Feb, 2026 Comments (15)
Biosimilars aren't like generics-they need advanced safety monitoring to track immune reactions and ensure patient safety. Learn how adverse event reporting, traceability, and AI-driven surveillance keep these complex drugs safe in real-world use.
View More
